MedDRA - Medical Dictionary for Regulatory Activities
Showing 1 - 25 of >10,000
Learn More About How Safe Dienogest is and How Well it Works
Recruiting
- Endometriosis Associated Pelvic Pain
- Dienogest (BAY86-5258, Visanne)
-
Multiple Locations, IndiaMany Locations
Jan 16, 2023
COVID-19 Trial in Tehran (Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, SARS-CoV-2 recombinant spike
Completed
- COVID-19
- Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
-
Tehran, Iran, Islamic Republic ofOrchid Life Department, Orchid Pharmed Company
Oct 13, 2022
Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )
Completed
- Covid19
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
- Saline placebo
-
Tehran, Iran, Islamic Republic ofEspinas Palace Hotel
Oct 11, 2022
Relative Bioavailability Trial (PanCytoVir™ 100 mg/mL oral suspension, Probenecid 500 mg)
Not yet recruiting
- Relative Bioavailability
- PanCytoVir™ 100 mg/mL oral suspension
- Probenecid 500 mg
- (no location specified)
Sep 5, 2023
Pancreatic Tumor, Digestive System Tumor, Tumors by Site Trial
Not yet recruiting
- Pancreatic Neoplasm
- +7 more
- (no location specified)
Apr 19, 2022
Medical Oncology, Palliative Care, Quality of Life Trial in Kiel, Lübeck, Hamburg (Cannabisextrakt Avextra 10/10 Lösung)
Not yet recruiting
- Medical Oncology
- +3 more
- Cannabisextrakt Avextra 10/10 Lösung
-
Kiel, Schleswig-Holstein, Germany
- +2 more
Oct 18, 2023
Idiopathic Pulmonary Fibrosis Trial in Shanghai (SC1011, Placebo tablet)
Completed
- Idiopathic Pulmonary Fibrosis
- SC1011
- Placebo tablet
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Nov 14, 2023
Healthy Adults Trial in Fayetteville (CBN and CBD)
Completed
- Healthy Adults
- CBN and CBD
-
Fayetteville, ArkansasRemote
Apr 21, 2023
Trastuzumab Emtansine as Therapy in Chinese HER2 Positive
Not yet recruiting
- Breast Cancer
- Trastuzumab emtansine
- (no location specified)
Jul 13, 2023
Compare Verbal Scores of Children Diagnosed With ASD Who
Completed
- Autism Spectrum Disorder
- Hyperbaric Oxygen Therapy
-
Brighton, Michigan
- +1 more
Sep 18, 2023
Healthy Participants Trial in Glendale (ASP8731, ASP8731 Matching Placebo)
Recruiting
- Healthy Participants
- ASP8731
- ASP8731 Matching Placebo
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group
Jul 26, 2022
Secondary Hyperparathyroidism Trial (SHR6508, Cinacalcet)
Not yet recruiting
- Secondary Hyperparathyroidism
- (no location specified)
Dec 21, 2022
EXploring Immune-related Adverse Events of Immune checkpoinT
Active, not recruiting
- Cancer
- +2 more
- Immune checkpoint inhibitor
-
Paris, France
- +1 more
Jul 5, 2023
Allergic to House Dust Mites Trial in Berlin, Hannover (ASP2390, Placebo)
Active, not recruiting
- Allergic to House Dust Mites
- ASP2390
- Placebo
-
Berlin, Germany
- +1 more
Jan 16, 2023
Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )
Completed
- Covid19
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
- Saline placebo
-
Tehran, Iran, Islamic Republic ofEspinas Palace Hotel
Oct 11, 2022
Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- (no location specified)
Jul 10, 2023
Behçet's Disease, Juvenile Psoriatic Arthritis Trial (Apremilast)
Not yet recruiting
- Behçet's Disease
- Juvenile Psoriatic Arthritis
- (no location specified)
Mar 8, 2023
Diabetic Peripheral Neuropathic Pain Trial (RTA 901, Placebo)
Not yet recruiting
- Diabetic Peripheral Neuropathic Pain
- RTA 901
- Placebo
- (no location specified)
May 31, 2023
Urinary Bladder Cancer Trial in Tucson (Gemcitabine)
Not yet recruiting
- Urinary Bladder Cancer
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 21, 2022
Myasthenia Gravis, MuSK Trial in Cleveland, Philadelphia (Amifampridine Phosphate)
Active, not recruiting
- Myasthenia Gravis, MuSK
- Amifampridine Phosphate
-
Cleveland, Ohio
- +1 more
Jul 21, 2022
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)
Not yet recruiting
- Triple Negative Breast Cancer
- +13 more
- (no location specified)
Aug 29, 2023